Reference

Increased sensitivity of canine sarcoma cells to lysis with alloantiserum and complement after pretreatment of cells with doxorubicin hydrochloride

Increased sensitivity of canine sarcoma cells to lysis with alloantiserum and complement after pretreatment of cells with doxorubicin hydrochloride. Madewell, B. R.In this study， 50-76-0 and 59-05-2 are also used.; Grant, C. K. (Sch. Vet. Med., Univ. California, Davis, Calif., USA). Am. J. Vet. Res., 38(3), 333-5 (English) 1977. CODEN: AJVRAH. DOCUMENT TYPE: Journal CA Section: 1 (Pharmacodynamics) Section cross-reference(s): 15 The 51Cr release assay was used to detect lysis of canine sarcoma cells incubated in vitro with alloantiserum and complement. Preincubation of the target cells with the anti-cancer agent doxorubicin-HCl [25316-40-9] increased the sensitivity of the cells to antibody-mediated lysis. The effect was dependent upon drug dose and was not reproduced by treatment with methotrexate [59-05-2], cytarabine [147-94-4], or dactinomycin [50-76-0]. The observation suggests a possible ancillary mode of action for doxorubicin-HCl on neoplastic cells. .

Studies on the stability of solid preparations for injection use after solubilization

Studies on the stability of solid preparations for injection use after solubilization. 12. Mine, Masatoshi; Kiyofuji, Eiichi (Fac. Med., Kyushu Univ., Fukuoka, Japan). Gekkan Yakuji, 19(1), 167-73 (Japanese) 1977. CODEN: YAKUD5. 473-41-6 and 9002-07-7 which are cas registry numbers of chemicals are mentioned. DOCUMENT TYPE: Journal CA Section: 63 (Pharmaceuticals) After dissolving com. available solid injection prepns., the stability and properties of doxorubicin-HCl [25316-40-9], tridocelan [62154-08-9], trypsin [9002-07-7], Na tolbutamide [473-41-6], nitromin [302-70-5], Na nafcillin [985-16-0], and nicametate citrate [1641-74-3] are reported. .